Niousha Zadeh
Co-Founder & CEO
Profile summary: Brite Health • Co-Founder & CEO
Brite Health
Brite Health offers an AI-powered platform that accelerates drug discovery and development by applying machine learning to biological data, including genomics, proteomics, and clinical datasets. The platform predicts drug efficacy and safety profiles, identifies potential drug targets and biomarkers, and flags adverse effects early to improve clinical trial success rates. This enables pharmaceutical companies and biotech firms to make more informed decisions and reduce development costs.
- Drug Discovery & Therapeutics
- Artificial Intelligence
- Biotechnology
- Healthcare Technology
- Software Only
- Data & Analytics
- Digital Health
Updated 1 month ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Problem
Traditional drug development is a lengthy and expensive process with high failure rates due to the complexity of biological data and the difficulty in predicting drug efficacy and safety early in the development pipeline. Identifying promising drug candidates and potential risks requires extensive experimentation and analysis, leading to significant costs and delays.
Solution
Brite Health offers an AI-powered platform that accelerates drug discovery and development by leveraging machine learning algorithms to analyze biological data and predict drug efficacy and safety. The platform identifies promising drug candidates earlier in the process, reducing the need for extensive experimentation and improving the success rate of clinical trials. By providing insights into potential risks and efficacy, Brite Health's platform enables more informed decision-making, ultimately reducing costs and accelerating the delivery of new therapies to patients.
Target Audience
Brite Health's primary customers are pharmaceutical companies, biotechnology firms, and research institutions involved in drug discovery and development.
Features
- Machine learning algorithms for analyzing biological data, including genomics, proteomics, and clinical data
- Predictive models for assessing drug efficacy and safety profiles
- Identification of potential drug targets and biomarkers
- Risk assessment tools to identify potential adverse effects early in development
- Data visualization and reporting tools for easy interpretation of results